Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice

Peptides

Volumn 30, Issue 7, 2009, Pages 1318-1322

  Moriya, Ryuichi ^a   Mashiko, Satoshi ^a   Ishihara, Akane ^a   Takahashi, Toshiyuki ^a   Murai, Takashi ^a   Ito, Junko ^a   Mitobe, Yuko ^a   Oda, Zenjun ^a   Iwaasa, Hisashi ^a   Takehiro, Fukami ^a   Kanatani, Akio ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

NPY Y2 receptor; NPY Y5 receptor; PYY(3 36)

Indexed keywords

3 OXO N (5 PHENYLPYRAZINYL) SPIRO (ISOBENZOFURAN 1(3H) 4' PIPERIDINE) 1' CARBOXAMIDE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y5 RECEPTOR; PEPTIDE YY [3-36]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIGENIC ACTIVITY; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; FOOD INTAKE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

ADIPOSITY; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; DIETARY FATS; EATING; MALE; MICE; MICE, INBRED C57BL; OBESITY; PEPTIDE YY; RECEPTORS, NEUROPEPTIDE Y;

MUS; RODENTIA;

EID: 67349226324     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.04.006     Document Type: Article

References (19)

1. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044 (2005) 127-131
2. Abbott C.R., Small C.J., Kennedy A.R., Neary N.M., Sajedi A., Ghatei M.A., et al. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res 1043 (2005) 139-144
3. Adams S.H., Lei C., Jodka C.M., Nikoulina S.E., Hoyt J.A., Gedulin B., et al. PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. J Nutr 136 (2006) 195-201
4. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 (2002) 650-654
5. Bray G.A., and Tartaglia L.A. Medicinal strategies in the treatment of obesity. Nature 404 (2000) 672-677
6. Chamorro S., Della-Zuana O., Fauchere J.L., Feletou M., Galizzi J.P., and Levens N. Appetite suppression based on selective inhibition of NPY receptors. Int J Obes Relat Metab Disord 26 (2002) 281-298
7. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., et al. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 129 (2005) 1430-1436
8. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., et al. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382 (1996) 168-171
9. Ishihara A., Kanatani A., Mashiko S., Tanaka T., Hidaka M., Gomori A., et al. A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. Proc Natl Acad Sci USA 103 (2006) 7154-7158
10. Kanatani A., Mashiko S., Murai N., Sugimoto N., Ito J., Fukuroda T., et al. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141 (2000) 1011-1016
11. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146 (2005) 2369-2375
12. Marsh D.J., Hollopeter G., Kafer K.E., and Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4 (1998) 718-721
13. Mashiko S., Ishihara A., Iwaasa H., Moriya R., Kitazawa H., Mitobe Y., et al. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine. Obesity (Silver Spring) 16 (2008) 1510-1515
14. Mashiko S., Ishihara A., Iwaasa H., Sano H., Ito J., Gomori A., et al. A pair-feeding study reveals that a Y5 antagonist causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure. Mol Pharmacol 71 (2007) 602-608
15. Nonaka N., Shioda S., Niehoff M.L., and Banks W.A. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J Pharmacol Exp Ther 306 (2003) 948-953
16. Pittner R.A., Moore C.X., Bhavsar S.P., Gedulin B.R., Smith P.A., Jodka C.M., et al. Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord 28 (2004) 963-971
17. Reidelberger R.D., Haver A.C., Chelikani P.K., and Buescher J.L. Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 295 (2008) R449-R458
18. van den Hoek A.M., Heijboer A.C., Voshol P.J., Havekes L.M., Romijn J.A., Corssmit E.P., et al. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice. Am J Physiol Endocrinol Metab 292 (2007) E238-E245
19. Vrang N., Madsen A.N., Tang-Christensen M., Hansen G., and Larsen P.J. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 291 (2006) R367-R375